Erratum: Guillain-Barré and Miller Fisher syndromes - New diagnostic classification (Nature Reviews Neurology (2014) 10 (537-544) DOI: 10.1038/nrneurol.2014.138);Guillain-Barré and miller fisher syndromes - New diagnostic classification

Nature Reviews Neurology

Volumn 10, Issue 9, 2014, Pages 537-544

  Wakerley, Benjamin R ^a   Uncini, Antonino ^b   Yuki, Nobuhiro ^c  

^a GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CHIETI   (Italy)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE GM1 ANTIBODY; GANGLIOSIDE GQ 1B ANTIBODY; GD1A ANTIBODY; GT1A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG;

ACUTE INFLAMMATORY DEMYELINATING POLYNEUROPATHY; ACUTE MOTOR AXONAL NEUROPATHY; ANTIBODY DETECTION; AREFLEXIA; ATAXIA; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL FEATURE; DEMYELINATING NEUROPATHY; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FACIAL NERVE PARALYSIS; GUILLAIN BARRE SYNDROME; HUMAN; INCIDENCE; MUSCLE WEAKNESS; NERVE CONDUCTION; OPHTHALMOPLEGIA; PARAPLEGIA; PERIPHERAL NEUROPATHY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SOMNOLENCE;

GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOTHERAPY; MILLER FISHER SYNDROME;

EID: 84908099623     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2014.190     Document Type: Erratum

References (70)

1. Guillain, G., Barré, J. A. & Strohl, A. Sur un syndrome de radiculonévrite avec hyperalbuminose du liquide céphalo-rachidien sans réaction cellulaire: remarques sur les caractères cliniques et graphiques des réflexes tendineux [French]. Bull. Mem. Hop. Paris 40, 1462-1470 (1916).
2. Guillain, G. Les polyradiculonévrites avec dissociation alumbinocytologique et á evolution favorable (syndrome de Guillain et Barré) [French]. J. Belge Neurol. Psychiatr. 38, 323-329 (1938).
3. Fisher, M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N. Engl. J. Med. 255, 57-65 (1956).
4. Bickerstaff, E. R. Brain-stem encephalitis: further observations on a grave syndrome with benign prognosis. Br. Med. J. 1, 1384-1387 (1957).
5. Asbury, A. K., Arnason, B. G., Karp, H. R. & McFarlin, D. E. Criteria for diagnosis of Guillain-Barré syndrome. Ann. Neurol. 3, 565-566 (1978).
6. Asbury, A. K. & Cornblath, D. R. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann. Neurol. 27 (Suppl.), S21-S24 (1990).
7. Ropper, A. H. Unusual clinical variants and signs in Guillain- Barré syndrome. Arch. Neurol. 43, 1150-1152 (1986).
8. Ropper, A. H. Further regional variants of acute immune polyneuropathy: bifacial weakness or sixth nerve paresis with paresthesias, lumbar polyradiculopathy, and ataxia with pharyngeal-cervical-brachial weakness. Arch. Neurol. 51, 671-675 (1994).
9. Ropper, A. H., Wijdicks, E. F. M. & Truax, B. Guillain-Barré Syndrome (F. A. Davis, 1990).
10. van der Meché, F. G. et al. Diagnostic and classification criteria for the Guillain-Barré syndrome. Eur. Neurol. 45, 133-139 (2001).
11. Sejvar, J. J. et al. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 29, 599-612 (2011).
12. Wakerley, B. R. & Yuki, N. Pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. J. Neurol. Neurosurg. Psychiatry 85, 339-344 (2013).
13. Richter, R. B. The ataxic form of polyradiculoneuritis (Landry-Guillain-Barré syndrome): clinical and pathologic observations. J. Neuropathol. Exp. Neurol. 21, 171-184 (1962).
14. Kimoto, K. et al. Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies. Neurology 67, 1837-1843 (2006).
15. Mizoguchi, K. et al. Two species of antiganglioside antibodies in a patient with a pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. J. Neurol. Neurosurg. Psychiatry 57, 1121-1123 (1994).
16. Miura, Y., Susuki, K., Yuki, N., Ayabe, M. & Shoji, H. Guillain-Barré syndrome presenting pharyngeal-cervical-brachial weakness in the recovery phase. Eur. Neurol. 48, 53-54 (2002).
17. Koike, H. et al. Clinicopathological features of acute autonomic and sensory neuropathy. Brain 133, 2881-2896 (2010).
18. Koike, H. et al. The spectrum of clinicopathological features in pure autonomic neuropathy. J. Neurol. 259, 2067-2075 (2012).
19. Ohyama, K. et al. Autonomic manifestations in acute sensory ataxic neuropathy: a case report. Auton. Neurosci. 179, 155-158 (2013).
20. Uncini, A. & Yuki, N. Sensory Guillain-Barré syndrome and related disorders: an attempt at systematization. Muscle Nerve 45, 464-470 (2012).
21. Pan, C. L., Yuki, N., Koga, M., Chiang, M. C. & Hsieh, S. T. Acute sensory ataxic neuropathy associated with monospecific anti-GD1b IgG antibody. Neurology 57, 1316-1318 (2001).
22. Yuki, N., Odaka, M. & Hirata, K. Acute ophthalmoparesis (without ataxia) associated with anti-GQ1b IgG antibody: clinical features. Ophthalmology 108, 196-200 (2001).
23. Kokubun, N. et al. Conduction block in acute motor axonal neuropathy. Brain 133, 2897-2908 (2010).
24. Arai, M., Susuki, K. & Koga, M. Axonal pharyngeal-cervical-brachial variant of Guillain-Barré syndrome without anti-GT1a IgG antibody. Muscle Nerve 28, 246-250 (2003).
25. Nagashima, T. et al. Paraparetic Guillain-Barré syndrome: extending the axonal spectrum. Neurol. Clin. Neurosci. 1, 224-226 (2013).
26. Umapathi, T., Tan, E. Y., Kokubun, N., Verma, K. & Yuki, N. Non-demyelinating, reversible conduction failure in Fisher syndrome and related disorders. J. Neurol. Neurosurg. Psychiatry 83, 941-948 (2012).
27. Susuki, K., Koga, M., Hirata, K., Isogai, E. & Yuki, N. A Guillain-Barré syndrome variant with prominent facial diplegia. J. Neurol. 256, 1899-1905 (2009).
28. Uncini, A., Susuki, K. & Yuki, N. Nodo-paranodopathy: beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies. Clin. Neurophysiol. 124, 1928-1934 (2013).
29. Shahrizaila, N. & Yuki, N. Bickerstaff brainstem encephalitis and Fisher syndrome: anti-GQ1b antibody syndrome. J. Neurol. Neurosurg. Psychiatry 84, 576-583 (2013).
30. Ito, M. et al. Bickerstaff's brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases. J. Neurol. 255, 674-682 (2008).
31. Chiba, A., Kusunoki, S., Obata, H., Machinami, R. & Kanazawa, I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 43, 1911-1917 (1993).
32. Liu, J. X., Willison, H. J. & Pedrosa-Domellof, F. Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles. Invest. Ophthalmol. Vis. Sci. 50, 3226-3232 (2009).
33. Ito, M., Matsuno, K., Sakumoto, Y., Hirata, K. & Yuki, N. Ataxic Guillain-Barré syndrome and acute sensory ataxic neuropathy form a continuous spectrum. J. Neurol. Neurosurg. Psychiatry 82, 294-299 (2011).
34. Jindal, G., Parmar, V. R. & Gupta, V. K. Isolated ptosis as acute ophthalmoplegia without ataxia, positive for anti-GQ1b immunoglobulin G. Pediatr. Neurol. 41, 451-452 (2009).
35. Yuki, N., Koga, M. & Hirata, K. Isolated internal ophthalmoplegia associated with immunoglobulin G anti-GQ1b antibody. Neurology 51, 1515-1516 (1998).
36. Yuki, N., Susuki, K. & Hirata, K. Ataxic Guillain-Barré syndrome with anti-GQ1b antibody: relation to Miller Fisher syndrome. Neurology 54, 1851-1853 (2000).
37. Yuki, N. & Uncini, A. Acute and chronic ataxic neuropathies with disialosyl antibodies: a continuous clinical spectrum and a common pathophysiological mechanism. Muscle Nerve 49, 629-635 (2014).
38. Notturno, F., Caporale, C. M. & Uncini, A. Acute sensory ataxic neuropathy with antibodies to GD1b and GQ1b gangliosides and prompt recovery. Muscle Nerve 37, 265-268 (2008).
39. Willison, H. J., Almemar, A., Veitch, J. & Thrush, D. Acute ataxic neuropathy with cross-reactive antibodies to GD1b and GD3 gangliosides. Neurology 44, 2395-2397 (1994).
40. Koga, M., Yoshino, H., Morimatsu, M. & Yuki, N. Anti-GT1a IgG in Guillain-Barré syndrome. J. Neurol. Neurosurg. Psychiatry 72, 767-771 (2002).
41. Nagashima, T., Koga, M., Odaka, M., Hirata, K. & Yuki, N. Continuous spectrum of pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. Arch. Neurol. 64, 1519-1523 (2007).
42. O'Leary, C. P. et al. Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides. J. Neurol. Neurosurg. Psychiatry 61, 649-651 (1996).
43. Ogawara, K. et al. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann. Neurol. 48, 624-631 (2000).
44. McKhann, G. M. et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann. Neurol. 33, 333-342 (1993).
45. Yuki, N. et al. Guillain-Barré syndrome associated with normal or exaggerated tendon reflexes. J. Neurol. 259, 1181-1190 (2012).
46. Jackson, C. E., Barohn, R. J. & Mendell, J. R. Acute paralytic syndrome in three American men: comparison with Chinese cases. Arch. Neurol. 50, 732-735 (1993).
47. Yuki, N. & Hirata, K. Preserved tendon reflexes in Campylobacter neuropathy. Ann. Neurol. 43, 546-547 (1998).
48. Kuwabara, S. et al. Hyperreflexia in axonal Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis. J. Neurol. Sci. 199, 89-92 (2002).
49. Fokke, C. et al. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain 137, 33-43 (2014).
50. Baheti, N. N., Manuel, D., Shinde, P. D., Radhakrishnan, A. & Nair, M. Hyperreflexic Guillain-Barré syndrome. Ann. Indian Acad. Neurol. 13, 305-307 (2010).
51. Nishimoto, Y., Odaka, M., Hirata, K. & Yuki, N. Usefulness of anti-GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid examination. J. Neuroimmunol. 148, 200-205 (2004).
52. Uncini, A., Manzoli, C., Notturno, F. & Capasso, M. Pitfalls in electrodiagnosis of Guillain-Barré syndrome subtypes. J. Neurol. Neurosurg. Psychiatry 81, 1157-1163 (2010).
53. An ad hoc subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 41, 617-618 (1991).
54. Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-first revision. J. Peripher. Nerv. Syst. 15, 1-9 (2010).
55. Rajabally, Y. A., Nicolas, G., Pieret, F., Bouche, P. & Van den Bergh, P. Y. Validity of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy: a multicentre European study. J. Neurol. Neurosurg. Psychiatry 80, 1364-1368 (2009).
56. Ichikawa, H. et al. Unilateral oculomotor nerve palsy associated with anti-GQ1b IgG antibody. Neurology 59, 957-958 (2002).
57. Logullo, F., Manicone, M., Di Bella, P. & Provinciali, L. Asymmetric Guillain-Barré syndrome. Neurol. Sci. 27, 355-359 (2006).
58. Susuki, K., Yuki, N., Muramatsu, M. & Hirata, K. Unilateral ophthalmoparesis and limb ataxia associated with anti-GQ1b IgG antibody. J. Neurol. 247, 652-653 (2000).
59. Ruts, L., van Koningsveld, R. & van Doorn, P. A. Distinguishing acute-onset CIDP from Guillain-Barré syndrome with treatment related fluctuations. Neurology 65, 138-140 (2005).
60. Kuitwaard, K., van Koningsveld, R., Ruts, L., Jacobs, B. C. & van Doorn, P. A. Recurrent Guillain-Barré syndrome. J. Neurol. Neurosurg. Psychiatry 80, 56-59 (2009).
61. Mossberg, N. et al. The recurrent Guillain-Barré syndrome: a long-term population-based study. Acta Neurol. Scand. 126, 154-161 (2012).
62. Ropper, A. H. The Guillain-Barré syndrome. N. Engl. J. Med. 326, 1130-1136 (1992).
63. Nagashima, T., Odaka, M., Koga, M., Yuki, N. & Hirata, K. A case of pharyngeal-cervical-brachial weakness suggestive of the nosological continuity between acute oropharyngeal palsy [Japanese]. Rinsho Shinkeigaku 42, 523-526 (2002).
64. Bickerstaff, E. R. & Cloake, P. C. Mesencephalitis and rhombencephalitis. Br. Med. J. 2, 77-81 (1951).
65. Odaka, M. et al. Bickerstaff's brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barré syndrome. Brain 126, 2279-2290 (2003).
66. Wakerley, B. R., Soon, D., Chan, Y. C. & Yuki, N. Atypical Bickerstaff brainstem encephalitis: ataxic hypersomnolence without ophthalmoplegia. J. Neurol. Neurosurg. Psychiatry 84, 1206-1207 (2013).
67. Lin, J. J. et al. Clinical variants of Guillain-Barré syndrome in children. Pediatr. Neurol. 47, 91-96 (2012).
68. Ropper, A. H. & Samuels, M. A. Adam's and Victor's Principle of Neurology 9th edn 1251-1325 (McGraw-Hill, 2009).
69. Sakakibara, R. et al. Prevalence and mechanism of bladder dysfunction in Guillain-Barré syndrome. Neurourol. Urodyn. 28, 432-437 (2009).
70. Yanagihara, N., Mori, H., Kozawa, T., Nakamura, K. & Kita, M. Bell's palsy. Nonrecurrent v recurrent and unilateral v bilateral. Arch. Otolaryngol. 110, 374-377 (1984).